MedPath

Fertility Preservation in Cases of Klinefelter Syndrome.

Not Applicable
Completed
Conditions
Klinefelter Syndrome
Interventions
Procedure: Seminal analyses and testicular biopsy
Registration Number
NCT01918280
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Klinefelter Syndrome (KS) is the most common sex chromosomal abnormalities (1/600 newborn males), and is characterized by a hypergonadism hypogonadism. Until few years ago, mostly non-mosaic KS was considered as a model of a complete male infertility although few KS (4-8%) have an oligospermia. Recent studies in adult with non-mosaic KS reported the possibility of sperm retrieval by testicular biopsy (TESE) in around 50% cases and more than some pregnancies have been obtained after TESE with Intracytoplasmic Sperm Injection (ICSI). Since 1997, more than one hundred births are described.

As some studies shown a decrease of successful sperm retrieval with the increasing of age, we plan to compare the potential of sperm retrieval between two groups "adult" (23-55 years) and "young" after the onset of puberty (15-22 years). The study will be performed by searching spermatozoa on two seminal analyses spaced out 3 months followed by a testicular biopsy if the azoospermia is confirmed on semen analyses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
141
Inclusion Criteria
  • Klinefelter Syndrome with 47,XXY non-mosaic
  • Androgenotherapy stopped since more than 6 months
Exclusion Criteria
  • Antecedent of Radiotherapy or chemotherapy
  • Psychological trouble
  • Treatment interfering with spermatogenesis
  • Androgenotherapy non stopped

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Young groupSeminal analyses and testicular biopsyPatient aged 15-22 years for seminal analyses and testicular biopsy
Adult groupSeminal analyses and testicular biopsyPatient aged 23-55 years for seminal analyses and testicular biopsy
Primary Outcome Measures
NameTimeMethod
TEsticular Sperm Extraction (TESE)15 months

Improvement of sperm retrieval rate by Testicular Sperm extraction (TESE) in the "Young" group compare to "Adult" group.

Secondary Outcome Measures
NameTimeMethod
Androgenotherapy15 months

Influence of antecedent of androgenotherapy before Testicular Sperm extraction (TESE) : treatment or not, duration of treatment

Prognosis factors15 months

Identification of prognosis factors of sperm retrieval (by TESE) in the two groups "Young" and "Adult"

Histopathologist analyses15 months

Histopathologist analyses of testicular biopsy in the two groups "Young" and "Adult". In the 2 groups, comparison of cases with and without sperm.

Trial Locations

Locations (4)

Service de Biologie de la Reproduction - CECOS - Groupe Hospitalier Pellegrin

🇫🇷

Bordeaux, France

Service d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon

🇫🇷

Bron, France

Service de Biologie de la Reproduction - Hôpital de la Conception

🇫🇷

Marseille, France

Groupe de Médecine de la Reproduction - CECOS Midi-Pyrénées - Hôpital Paule de Viguier)

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath